Position in FBIO
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Derivatives in FBIO
reported options exposure · as of Mar 31, 2026CallValue
$1,674
CallShares
600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WOLVERINE ASSET MANAGEMENT LLC holds $4,246,654 across 11 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
125,265 | $1,811,331 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
22,815 | $1,713,178 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,322 | $249,924 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
9,500 | $203,680 | |
| 5 | SRPT |
Sarepta Therapeutics, Inc.
|
4,920 | $107,059 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,521 | $72,353 | |
| 7 | OABIW |
OmniAb, Inc.
|
27,325 | $42,900 | |
| 8 | YDES |
YD Bio Ltd
|
4,886 | $37,622 |
All Filings in FBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,674 | 600 | Call | Defined | 2026-05-04 | |
| 2025-12-31 | $2,196 | 600 | Call | Defined | 2026-02-02 | |
| 2025-09-30 | $2,220 | 600 | Call | Defined | 2025-10-28 | |
| No filing history on record for this holder in this stock. | ||||||